Ratings by Wolfe Research (Doug Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/26/2026 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Bruker | BRKR | Upgrade | Outperform (Peerperform) |
45.36 (36.68) |
-19.14% | Details | |
| 12/10/2025 | Waters Corp. | WAT | Upgrade | Outperform (Peerperform) |
386.16 (302.54) |
-21.65% | Details | |
| 11/21/2025 | Exact Sciences | EXAS | Downgrade | Peerperform (Outperform) |
86.18 (103.50) |
20.1% | Details | |
| 10/30/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2025 | Guardant Health | GH | Upgrade | Outperform (Peerperform) |
57.67 (91.20) |
58.14% | Details | |
| 7/21/2025 | Avantor Inc. | AVTR | Maintain | Peerperform (N/A) |
|
Details | ||
| 7/14/2025 | Caris Life Sciences Inc | CAI | New Coverage | Outperform (N/A) |
26.51 (18.59) |
-29.88% | Details | |
| 5/8/2025 | Myriad Genetics | MYGN | Downgrade | Peerperform (Outperform) |
7.27 (5.15) |
-29.16% | Details | |
| 4/29/2025 | Repligen | RGEN | Upgrade | Outperform (Peerperform) |
143.63 (119.99) |
-16.46% | Details | |
| 3/4/2025 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2024 | Stevanato Group S.p.A. | STVN | New Coverage | Outperform (N/A) |
22.47 (15.41) |
-31.42% | Details | |
| 12/13/2024 | West Pharmaceutical | WST | New Coverage | Peerperform (N/A) |
331.62 (245.86) |
-25.86% | Details | |
| 12/13/2024 | Mettler-Toledo | MTD | New Coverage | Peerperform (N/A) |
1276.92 (1209.65) |
-5.27% | Details | |
| 12/13/2024 | Tempus AI Inc | TEM | New Coverage | Outperform (N/A) |
41.99 (52.26) |
24.46% | Details | |
| 12/13/2024 | Twist Bioscience | TWST | New Coverage | Outperform (N/A) |
47.39 (46.94) |
-0.95% | Details | |
| 12/13/2024 | Hologic | HOLX | New Coverage | Peerperform (N/A) |
75.09 (75.74) |
0.87% | Details | |
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2024 | GRAIL, Inc. | GRAL | New Coverage | Peerperform (N/A) |
15.81 (50.23) |
217.71% | Details | |
| 11/15/2024 | Veracyte, Inc | VCYT | New Coverage | Outperform (N/A) |
37.04 (33.85) |
-8.61% | Details | |
| 11/14/2024 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Peerperform (N/A) |
5.63 (3.55) |
-36.94% | Details | |
| 11/14/2024 | Repligen | RGEN | New Coverage | Peerperform (N/A) |
150.47 (119.99) |
-20.26% | Details | |
| 11/4/2024 | Danaher | DHR | Upgrade | Outperform (Peerperform) |
245.66 (195.50) |
-20.42% | Details | |
| 10/31/2024 | Danaher | DHR | Upgrade | Outperform (Peerperform) |
242.32 (245.66) |
1.38% | Details | |
| 9/30/2024 | Bruker | BRKR | Downgrade | Peerperform (Outperform) |
70.67 (45.36) |
-35.81% | Details | |
| 8/21/2024 | Myriad Genetics | MYGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Agilent | A | Downgrade | Peerperform (Outperform) |
134.69 (115.07) |
-14.57% | Details | |
| 6/27/2024 | Qiagen NV | QGEN | Upgrade | Outperform (Peerperform) |
41.04 (44.55) |
8.55% | Details | |
| 6/27/2024 | 10X Genomics | TXG | Downgrade | Peerperform (Outperform) |
19.59 (20.81) |
6.23% | Details | |
| 6/25/2024 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2024 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2024 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2023 | Guardant Health | GH | New Coverage | Peerperform (N/A) |
26.55 (57.67) |
117.21% | Details | |
| 12/13/2023 | Natera | NTRA | New Coverage | Outperform (N/A) |
56.70 (198.13) |
249.44% | Details | |
| 12/13/2023 | Bruker | BRKR | New Coverage | Outperform (N/A) |
69.24 (70.67) |
2.07% | Details | |
| 12/13/2023 | Myriad Genetics | MYGN | New Coverage | Outperform (N/A) |
19.05 (5.15) |
-72.97% | Details | |
| 12/13/2023 | 10X Genomics | TXG | New Coverage | Outperform (N/A) |
48.14 (20.81) |
-56.77% | Details | |
| 12/13/2023 | Exact Sciences | EXAS | New Coverage | Outperform (N/A) |
65.06 (86.18) |
32.46% | Details | |
| 12/13/2023 | Illumina | ILMN | New Coverage | Outperform (N/A) |
117.64 (124.62) |
5.93% | Details | |
| 12/13/2023 | Pacific Biosciences of California | PACB | New Coverage | Peerperform (N/A) |
8.39 (1.38) |
-83.55% | Details | |
| 12/13/2023 | Waters Corp. | WAT | New Coverage | Peerperform (N/A) |
296.37 (386.16) |
30.3% | Details | |
| 12/13/2023 | Avantor Inc. | AVTR | New Coverage | Peerperform (N/A) |
21.17 (8.17) |
-61.41% | Details | |
| 12/13/2023 | Danaher | DHR | New Coverage | Peerperform (N/A) |
221.35 (242.32) |
9.47% | Details | |
| 12/12/2023 | Thermo Fisher Scientific | TMO | New Coverage | Outperform (N/A) |
494.99 (501.97) |
1.41% | Details | |
| 12/12/2023 | Qiagen NV | QGEN | New Coverage | Peerperform (N/A) |
42.08 (44.55) |
5.87% | Details | |
| 12/12/2023 | Agilent | A | New Coverage | Outperform (N/A) |
128.97 (115.07) |
-10.78% | Details | |
| 12/12/2023 | Revvity Inc | RVTY | New Coverage | Peerperform (N/A) |
90.69 (91.34) |
0.72% | Details |
